Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
40.05x6.79x-7.96x10.89x28.03x31.75x0.88% 155.77Cr
17.95x2.36x2.75x4.83x12.27x14.67x0.5% 7.52TCr
58.66x7.89x1.4x15.52x33.29x41.68x-.--% 6.12TCr
44.56x4.73x7.12x7.05x23.06x30.99x0.53% 5.85TCr
22.43x2.8x-1.47x4.09x11.88x13.71x2.63% 5.65TCr
15.84x1.31x-2.21x2.63x8.29x9.16x-.--% 2.41TCr
17.13x3.62x0x3.39x10.17x10.32x-.--% 2.09TCr
81.94x7.95x-0.05x9.81x88.44x101.48x-.--% 1.99TCr
381.84x69.03x22.94x115.87x188.27x192.78x - 1.88TCr
-5.19x1.92x0.4x5.92x-3.49x-3.29x-.--% 1.63TCr
-22.28x-7.19x-1.18x32.03x-32.72x-31.76x-.--% 1.47TCr
-656.06x2.81x6.28x4.37x11.29x23.01x-.--% 1.24TCr
-16.19x - -0.29x582.69x-15.96x-16.12x-.--% 1.09TCr
20.6x1.7x1.04x2.9x14.42x14.02x-.--% 1.05TCr
-46.99x201.64x1.27x13.93x-58.14x-51.72x-.--% 893.66Cr
6.06x2.52x0.02x2.75x4.12x4.16x3% 847.98Cr
42.47x - 0.34x19.93x46.08x47.83x-.--% 826.55Cr
-249.34x - 0.76x - - - -.--% 818Cr
Average -13.70x 20.66x 1.73x 49.33x 21.72x 25.45x 0.44% 2.42TCr
Weighted average by Cap. 18.08x 10.96x 2.49x 27.65x 23.90x 28.26x 0.59%
Biopharmaceuticals